Indoco Remedies receives USFDA EIR for Patalganga API facility EP News Bureau Dec 12, 2025 USFDA inspection confirms compliance at Indoco Remedies’ Active Pharmaceutical Ingredients manufacturing site
Cipla announces closure of USFDA inspection at Patalganga facility Press Trust of India Jan 20, 2020 Following the inspection by USFDA in November last year, the company has received the Establishment Inspection Report (EIR),…
